[1]
“COLITIS DUE TO CANCER TREATMENT WITH IMMUNE CHECK-POINT INHIBITORS”, Radiol Oncol, vol. 58, no. 2, pp. 179–185, Jun. 2024, Accessed: Oct. 26, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4227